Key statistics
On Friday, Ascletis Pharma Inc (2VJ:STU) closed at 0.178, -23.28% below its 52-week high of 0.232, set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.178 |
---|---|
High | 0.178 |
Low | 0.178 |
Bid | 0.18 |
Offer | 0.189 |
Previous close | 0.175 |
Average volume | 1.14k |
---|---|
Shares outstanding | 979.99m |
Free float | 254.01m |
P/E (TTM) | -- |
Market cap | 1.52bn HKD |
EPS (TTM) | -0.2709 HKD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Press releases
- Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity
- Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity